Literature DB >> 25866190

The roles of nucleolin subcellular localization in cancer.

Caroline Madeleine Berger1, Xavier Gaume2, Philippe Bouvet3.   

Abstract

Nucleolin (NCL) is one of the most abundant non ribosomal protein of the nucleolus where it plays a central role in polymerase I transcription. NCL is also found outside of the nucleolus, in the nucleoplasm, cytoplasm as well as on the cell membrane. It acts in all cell compartments to control cellular homeostasis and therefore each cellular pool of NCL can play a different role in cancer development. NCL overexpression and its increased localization at the cell membrane is a common feature of several tumor cells. In cancer cells, NCL overexpression influences cell survival, proliferation and invasion through its action on different cellular pathways. In this review, we describe how the multiple functions of NCL that are associated to its multiple cellular localization can participate to the development of cancer.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Cancer; Cell proliferation; Nucleolar protein; Nucleolin; Ribosome biogenesis

Mesh:

Substances:

Year:  2015        PMID: 25866190     DOI: 10.1016/j.biochi.2015.03.023

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  71 in total

1.  In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.

Authors:  Daiqin Chen; Dongzhi Yang; Casey A Dougherty; Weifei Lu; Hongwei Wu; Xianran He; Ting Cai; Marcian E Van Dort; Brian D Ross; Hao Hong
Journal:  ACS Nano       Date:  2017-03-28       Impact factor: 15.881

2.  Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.

Authors:  Sayantani Das; Soumasree De; Sumita Sengupta
Journal:  Mol Biol Rep       Date:  2021-03-31       Impact factor: 2.316

3.  Shear stress regulation of miR-93 and miR-484 maturation through nucleolin.

Authors:  Brendan Gongol; Traci Marin; Jiao Zhang; Shen-Chih Wang; Wei Sun; Ming He; Shanshan Chen; Lili Chen; Jie Li; Jun-Hui Liu; Marcy Martin; Yue Han; Jian Kang; David A Johnson; Christian Lytle; Yi-Shuan Li; Po-Hsun Huang; Shu Chien; John Y-J Shyy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

4.  Nucleolin phosphorylation regulates PARN deadenylase activity during cellular stress response.

Authors:  Xiaokan Zhang; Shu Xiao; Rachele Dolce Rameau; Emral Devany; Zaineb Nadeem; Elif Caglar; Kenneth Ng; Frida Esther Kleiman; Anjana Saxena
Journal:  RNA Biol       Date:  2017-12-15       Impact factor: 4.652

5.  Targeting nucleolin for better survival in diffuse large B-cell lymphoma.

Authors:  N Jain; H Zhu; T Khashab; Q Ye; B George; R Mathur; R K Singh; Z Berkova; J F Wise; F K Braun; X Wang; K Patel; Z Y Xu-Monette; J Courty; K H Young; L Sehgal; F Samaniego
Journal:  Leukemia       Date:  2017-07-10       Impact factor: 11.528

Review 6.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

7.  Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.

Authors:  Zhen Yu; Xundou Li; Jinhong Duan; Xian-Da Yang
Journal:  Int J Nanomedicine       Date:  2020-09-11

8.  Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation.

Authors:  Cheng Xu; Yunfei Wang; Qiu Tu; Zhiye Zhang; Mengrou Chen; James Mwangi; Yaxiong Li; Yang Jin; Xudong Zhao; Ren Lai
Journal:  Oncogene       Date:  2018-10-24       Impact factor: 9.867

Review 9.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

10.  Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin.

Authors:  Rui Lopes; Kevin Shi; Nuno A Fonseca; Adelina Gama; José S Ramalho; Luís Almeida; Vera Moura; Sérgio Simões; Bruce Tidor; João N Moreira
Journal:  Drug Deliv Transl Res       Date:  2021-04-15       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.